Collegium Pharmaceutical (COLL) News Today $33.13 -0.26 (-0.78%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$34.17 +1.04 (+3.15%) As of 10/8/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock COLL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Collegium Pharmaceutical, Inc. (COLL): A Bull Case TheoryOctober 8 at 12:10 PM | insidermonkey.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Recommendation of "Buy" from AnalystsOctober 3, 2025 | marketbeat.comCollegium Pharmaceutical (NASDAQ:COLL) Upgraded at Zacks ResearchSeptember 26, 2025 | marketbeat.comChronic Lower Back Pain Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment | Collegium Pharma, Eli Lilly and Company, Camurus/Braeburn Inc ...September 17, 2025 | theglobeandmail.comCollegium Pharmaceutical (NASDAQ:COLL) Stock Price Down 4.7% - Should You Sell?September 17, 2025 | marketbeat.comGoldman Sachs Group Inc. Sells 44,391 Shares of Collegium Pharmaceutical, Inc. $COLLSeptember 17, 2025 | marketbeat.comQ2 Earnings Roundup: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals SegmentSeptember 16, 2025 | msn.comBelpointe Asset Management LLC Buys Shares of 13,660 Collegium Pharmaceutical, Inc. $COLLSeptember 16, 2025 | marketbeat.comAmundi Raises Stake in Collegium Pharmaceutical, Inc. $COLLSeptember 15, 2025 | marketbeat.comFortis Capital Advisors LLC Takes $408,000 Position in Collegium Pharmaceutical, Inc. $COLLSeptember 13, 2025 | marketbeat.com1 Safe-and-Steady Stock to Keep an Eye On and 2 Facing HeadwindsSeptember 12, 2025 | finance.yahoo.comCollegium Pharmaceutical, Inc. (COLL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 8, 2025 | seekingalpha.comRussell Investments Group Ltd. Sells 11,057 Shares of Collegium Pharmaceutical, Inc. $COLLSeptember 6, 2025 | marketbeat.comCollegium Pharmaceutical (NASDAQ:COLL) EVP Thomas Smith Sells 17,478 SharesSeptember 5, 2025 | marketbeat.comCollegium Pharmaceutical, Inc. (COLL) to Present 9 Pain Studies at PAINWeek 2025September 2, 2025 | finance.yahoo.comCollegium Pharmaceutical, Inc. $COLL Shares Purchased by Hsbc Holdings PLCSeptember 2, 2025 | marketbeat.comNuveen LLC Makes New $2.67 Million Investment in Collegium Pharmaceutical, Inc. $COLLAugust 31, 2025 | marketbeat.comCollegium Pharmaceutical, Inc. (COLL) Highlights Real-World Evidence at PAINWeek 2025August 29, 2025 | finance.yahoo.comQuantbot Technologies LP Acquires Shares of 14,922 Collegium Pharmaceutical, Inc. $COLLAugust 29, 2025 | marketbeat.comCollegium to Participate in Upcoming Investor ConferencesAugust 28, 2025 | globenewswire.comCampbell & CO Investment Adviser LLC Takes Position in Collegium Pharmaceutical, Inc. $COLLAugust 28, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $10.60 Million Holdings in Collegium Pharmaceutical, Inc. $COLLAugust 27, 2025 | marketbeat.comStonepine Capital Management LLC Makes New Investment in Collegium Pharmaceutical, Inc. $COLLAugust 26, 2025 | marketbeat.comVanguard Group Inc. Has $67.06 Million Holdings in Collegium Pharmaceutical, Inc. $COLLAugust 26, 2025 | marketbeat.comCollegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual MeetingAugust 25, 2025 | globenewswire.comLPL Financial LLC Has $1.34 Million Stock Position in Collegium Pharmaceutical, Inc. $COLLAugust 25, 2025 | marketbeat.com19,161 Shares in Collegium Pharmaceutical, Inc. $COLL Purchased by Advantage Alpha Capital Partners LPAugust 24, 2025 | marketbeat.comCollegium Pharmaceutical, Inc. $COLL Shares Sold by Versor Investments LPAugust 24, 2025 | marketbeat.comDeutsche Bank AG Sells 19,873 Shares of Collegium Pharmaceutical, Inc. $COLLAugust 24, 2025 | marketbeat.comGino Santini Sells 5,405 Shares of Collegium Pharmaceutical (NASDAQ:COLL) StockAugust 21, 2025 | marketbeat.comCollegium Pharmaceutical (COLL): Assessing Valuation Following Q2 Results and Upgraded Full-Year Revenue GuidanceAugust 21, 2025 | finance.yahoo.comCollegium Pharmaceutical (NASDAQ:COLL) EVP Scott Dreyer Sells 16,389 SharesAugust 21, 2025 | insidertrades.comFuller & Thaler Asset Management Inc. Grows Stake in Collegium Pharmaceutical, Inc. $COLLAugust 21, 2025 | marketbeat.comPublic Sector Pension Investment Board Has $3.05 Million Position in Collegium Pharmaceutical, Inc. $COLLAugust 21, 2025 | marketbeat.comGino Santini At Collegium Pharmaceutical Capitalizes: Options Exercised, Resulting In $362KAugust 20, 2025 | benzinga.comCollegium Pharmaceutical (NASDAQ:COLL) Director Sells $201,011.95 in StockAugust 20, 2025 | insidertrades.comBrandywine Global Investment Management LLC Purchases 13,792 Shares of Collegium Pharmaceutical, Inc. $COLLAugust 20, 2025 | marketbeat.comInvesco Ltd. Reduces Stake in Collegium Pharmaceutical, Inc. $COLLAugust 19, 2025 | marketbeat.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) EVP Sells $184,863.83 in StockAugust 17, 2025 | marketbeat.comTejara Capital Ltd Boosts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)August 17, 2025 | marketbeat.comInsider Selling: Collegium Pharmaceutical, Inc. (NASDAQ:COLL) EVP Sells 4,861 Shares of StockAugust 16, 2025 | insidertrades.comWe Think You Can Look Beyond Collegium Pharmaceutical's (NASDAQ:COLL) Lackluster EarningsAugust 15, 2025 | finance.yahoo.comConnor Clark & Lunn Investment Management Ltd. Makes New $3.09 Million Investment in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)August 15, 2025 | marketbeat.comInsider Selling: Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Director Sells 11,659 Shares of StockAugust 14, 2025 | marketbeat.comThe 5 Most Interesting Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings CallAugust 14, 2025 | finance.yahoo.com1 Stock Under $50 Worth Investigating and 2 We IgnoreAugust 14, 2025 | uk.finance.yahoo.comDirector Of Collegium Pharmaceutical Sold $400K In StockAugust 14, 2025 | benzinga.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Director Sells $400,603.24 in StockAugust 13, 2025 | insidertrades.comCOLL Q2 Deep Dive: Jornay Expansion Drives Revenue Guidance Increase, Margins Face Investment PressureAugust 12, 2025 | finance.yahoo.comCollegium Pharmaceutical Shows Market Leadership With Jump To 81 RS RatingAugust 12, 2025 | msn.com Get Collegium Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for COLL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. COLL Media Mentions By Week COLL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COLL News Sentiment▼1.230.63▲Average Medical News Sentiment COLL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COLL Articles This Week▼36▲COLL Articles Average Week Get the Latest News and Ratings for COLL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CRNX News Today PTGX News Today KYMR News Today MLTX News Today AKRO News Today ADMA News Today SRRK News Today MIRM News Today ACAD News Today ZLAB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COLL) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collegium Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
